Literature DB >> 2632560

Cardiovascular manifestations of aluminium phosphide intoxication.

R B Singh, S S Rastogi, D S Singh.   

Abstract

Aluminium phosphide (ALP) a major suicidal agent in the developing countries is freely available as grain fumigant. It is highly toxic to lungs, heart and blood vessels causing pulmonary oedema, shock and arrhythmias. There is massive focal myocardial damage resulting in raised cardiac enzymes. Clinical manifestations were nausea and vomiting (32), dyspnoea and palpitations (25 each), cyanosis (12), hypotension (12) and shock (15). Cardiac arrhythmias were present in 28 cases and hypermagnesaemia in 13 patients. Mean serum magnesium level (1.95 +/- 0.2O, mEq/L) was significantly raised compared to mean magnesium level in control subjects (1.62 +/- 0.23 mEq/L). Hypermagnesaemia occurs due to myocardial and liver damage. Out of 32 cases studied, 22 died 18 within 24 hours of ALP ingestion. Thirty two cases of ALP were studied.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2632560

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  9 in total

1.  Lethal heart failure caused by aluminium phosphide poisoning.

Authors:  P Alter; W Grimm; B Maisch
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

2.  Successful Management of Aluminium Phosphide Poisoning Resulting in Cardiac Arrest.

Authors:  Sedat Hakimoğlu; İsmail Dikey; Ali Sarı; Leyla Kekeç; Kasım Tuzcu; Murat Karcıoğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-03-03

3.  Intra-aortic balloon pump in toxic myocarditis due to aluminum phosphide poisoning.

Authors:  Latha Siddaiah; Srilakshmi Adhyapak; Santosh Jaydev; Gurappa Shetty; Kiron Varghese; Chandrakanth Patil; Shamanna Iyengar
Journal:  J Med Toxicol       Date:  2009-06

4.  Esophageal complications following aluminium phosphide ingestion: an emerging issue among survivors of poisoning.

Authors:  Rajendra K Jain; Narendra B Gouda; Virendra K Sharma; Tribhuvan N Dubey; Atul Shende; Rajesh Malik; Gurudutt Tiwari
Journal:  Dysphagia       Date:  2009-09-02       Impact factor: 3.438

5.  Evaluation of phosphine genotoxicity at occupational levels of exposure in New South Wales, Australia.

Authors:  A Barbosa; A M Bonin
Journal:  Occup Environ Med       Date:  1994-10       Impact factor: 4.402

6.  Managing aluminum phosphide poisonings.

Authors:  Mohan Gurjar; Arvind K Baronia; Afzal Azim; Kalpana Sharma
Journal:  J Emerg Trauma Shock       Date:  2011-07

7.  Aluminum phosphide poisoning: effect of correction of severe metabolic acidosis on patient outcome.

Authors:  S Jaiswal; R K Verma; N Tewari
Journal:  Indian J Crit Care Med       Date:  2009 Jan-Mar

8.  An update on toxicology of aluminum phosphide.

Authors:  Ali Akbar Moghadamnia
Journal:  Daru       Date:  2012-09-03       Impact factor: 3.117

9.  Outcome of patients supported by extracorporeal membrane oxygenation for aluminum phosphide poisoning: An observational study.

Authors:  Bishav Mohan; Bhupinder Singh; Vivek Gupta; Sarju Ralhan; Dinesh Gupta; Sandeep Puri; Abhishek Goyal; Naved Aslam; Rohit Tandon; Gurpreet Singh Wander
Journal:  Indian Heart J       Date:  2016-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.